The actual peptide content, purity, and handling conditions during shipping are unknown
Consulting with a healthcare provider to identify any allergies is critical before starting B12 therapy
The trial concluded that AOD-9604 did not induce significant weight loss, leading to a halt in the development of the drug as a weight-loss solution
The metabolism and elimination of NAD+ (and its by-products) could be altered in advanced hepatic or renal dysfunction, and high-dose NAD+ might theoretically affect cardiovascular dynamics, so practitioners generally avoid or closely supervise NAD+ use in such settings
These Vitamin B12 Injections are manufactured in our facilities in China, India, and the USA
An interesting finding from the study was the rapid reduction in lameness observed in rabbits receiving the combination of AOD9604 and HA, with full recovery noted in approximately 11 days